Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Human Stage Holdings Corp. (321A:JPX), powered by AI.
Human Stage Holdings Corp. is currently trading at ¥785. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Human Stage Holdings Corp. on Alpha Lenz.
Human Stage Holdings Corp.'s P/E ratio is 21.1.
“Human Stage Holdings Corp. trades at a P/E of 21.1 (fair value) with modest ROE of 2.4%.”
Ask for details →Human Stage Holdings Corp. is a diversified holding company involved in the management and operation of various subsidiaries across multiple industries. The primary function of this entity is to oversee and strategically guide its portfolio companies, optimizing value creation through efficient resource allocation and management expertise. Human Stage Holdings Corp. typically operates in sectors such as healthcare, technology, and consumer goods, thereby impacting a broad spectrum of markets and driving synergy between its diverse business units. As a holding company, it plays a crucial role in providing financial strength and stability to its subsidiaries, enabling them to focus on innovation and market expansion. Positioned at the intersection of strategic investment and operational management, Human Stage Holdings Corp. is significant in facilitating industry advancements through its dynamic and adaptable business model.
“Human Stage Holdings Corp. trades at a P/E of 21.1 (fair value) with modest ROE of 2.4%.”
Ask for details →Human Stage Holdings Corp. (ticker: 321A) is a company listed on JPX in the Industrials sector (Conglomerates). Market cap is $993M.
The current price is 785 with a P/E ratio of 21.06x and P/B of 0.5x.
ROE is 2.35% and operating margin is -1.17%. Annual revenue is $4.1B.